Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.

Abstract

BACKGROUND Long-term effects of lamivudine treatment on chronic hepatitis B patients without advanced disease remain unknown. Our aim was to investigate the effects of long-term lamivudine treatment and lamivudine-resistant virus (YMDD) on the development of cirrhosis and hepatocellular carcinoma (HCC) in asymptomatic patients without advanced disease… (More)

Topics

Cite this paper

@article{Yuen2007LongtermLT, title={Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.}, author={Man-Fung Yuen and Wai-Kay Seto and Danny Hoi-Fan Chow and Kit Tsui and Danny C. Wong and Vincent Wing-Shun Ngai and Benjamin Chun-yu Wong and James Fung and John Chi-hang Yuen and Ching-lung Lai}, journal={Antiviral therapy}, year={2007}, volume={12 8}, pages={1295-303} }